Legend Biotech (LEGN) News Today $35.05 -1.28 (-3.52%) Closing price 04:00 PM EasternExtended Trading$35.18 +0.13 (+0.37%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Legend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesShares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twelve research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and eleven have given a bMarch 25 at 4:55 AM | marketbeat.comiA Global Asset Management Inc. Buys New Stake in Legend Biotech Co. (NASDAQ:LEGN)iA Global Asset Management Inc. bought a new stake in Legend Biotech Co. (NASDAQ:LEGN - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 76,380 shares of the company's sMarch 23 at 5:05 AM | marketbeat.comSector Gamma AS Has $1.58 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)Sector Gamma AS raised its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 25.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 48,495 shares of the company's stock after acquiring an additional 9,733 shares during the quarter. SectMarch 22 at 6:51 AM | marketbeat.comDemystifying Legend Biotech: Insights From 5 Analyst ReviewsMarch 19, 2025 | benzinga.comSkandinaviska Enskilda Banken AB publ Sells 9,200 Shares of Legend Biotech Co. (NASDAQ:LEGN)Skandinaviska Enskilda Banken AB publ lessened its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 74.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,100 shares oMarch 19, 2025 | marketbeat.comZurcher Kantonalbank Zurich Cantonalbank Trims Position in Legend Biotech Co. (NASDAQ:LEGN)Zurcher Kantonalbank Zurich Cantonalbank decreased its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 18.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 40,913 shares of the company's stock after selling 9,355 shares during thMarch 19, 2025 | marketbeat.comBank of New York Mellon Corp Grows Stake in Legend Biotech Co. (NASDAQ:LEGN)Bank of New York Mellon Corp increased its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 12.5% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 131,416 shares of the company's stock after buying an additional 14,588 sMarch 19, 2025 | marketbeat.comMorgan Stanley Has Lowered Expectations for Legend Biotech (NASDAQ:LEGN) Stock PriceMarch 19, 2025 | americanbankingnews.comMorgan Stanley Issues Pessimistic Forecast for Legend Biotech (NASDAQ:LEGN) Stock PriceMorgan Stanley reduced their target price on shares of Legend Biotech from $82.00 to $80.00 and set an "overweight" rating for the company in a report on Monday.March 18, 2025 | marketbeat.comQ1 EPS Estimates for Legend Biotech Reduced by William BlairMarch 18, 2025 | americanbankingnews.comHC Wainwright Predicts Stronger Earnings for Legend BiotechMarch 18, 2025 | americanbankingnews.comMorgan Stanley Sticks to Their Buy Rating for Legend Biotech (LEGN)March 17, 2025 | markets.businessinsider.comLegend Biotech price target lowered to $80 from $82 at Morgan StanleyMarch 17, 2025 | markets.businessinsider.comHC Wainwright Boosts Earnings Estimates for Legend BiotechLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Analysts at HC Wainwright lifted their Q1 2025 earnings per share estimates for Legend Biotech in a research note issued on Wednesday, March 12th. HC Wainwright analyst M. Kapoor now expects that the company will post earnings per share of ($0.18)March 17, 2025 | marketbeat.comWilliam Blair Reduces Earnings Estimates for Legend BiotechLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Investment analysts at William Blair cut their Q1 2025 earnings per share (EPS) estimates for Legend Biotech in a research note issued on Wednesday, March 12th. William Blair analyst S. Corwin now forecasts that the company will post earnings per sMarch 17, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Stock Price Down 1.8% - Here's What HappenedLegend Biotech (NASDAQ:LEGN) Stock Price Down 1.8% - Should You Sell?March 15, 2025 | marketbeat.comQ4 EPS Estimates for Legend Biotech Lowered by HC WainwrightLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Analysts at HC Wainwright lowered their Q4 2025 earnings per share estimates for Legend Biotech in a note issued to investors on Wednesday, March 12th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings per share of $March 15, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Given Neutral Rating at GuggenheimMarch 15, 2025 | americanbankingnews.comLegend Biotech (NASDAQ:LEGN) Stock Price Expected to Rise, HC Wainwright Analyst SaysMarch 15, 2025 | americanbankingnews.comHC Wainwright Expects Reduced Earnings for Legend BiotechMarch 15, 2025 | americanbankingnews.comLegend Biotech Reports $963 Million in CARVYKTI® Sales for 2024 and Initiates Commercial Production at Novartis FacilityMarch 13, 2025 | nasdaq.comLegend Biotech (LEGN) Gets a Buy from BarclaysMarch 13, 2025 | markets.businessinsider.comLegend Biotech's (LEGN) "Neutral" Rating Reiterated at GuggenheimGuggenheim reaffirmed a "neutral" rating on shares of Legend Biotech in a research note on Wednesday.March 13, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Given New $75.00 Price Target at HC WainwrightHC Wainwright boosted their price target on Legend Biotech from $73.00 to $75.00 and gave the company a "buy" rating in a research note on Wednesday.March 13, 2025 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Trading 8% Higher - Still a Buy?Legend Biotech (NASDAQ:LEGN) Trading 8% Higher - Should You Buy?March 12, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Oculis Holding (OCS) and Meiragtx Holdings (MGTX)March 12, 2025 | markets.businessinsider.comTruist Financial Sticks to Its Buy Rating for Legend Biotech (LEGN)March 12, 2025 | markets.businessinsider.comLegend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | msn.comLegend Biotech (NASDAQ:LEGN) Announces Earnings ResultsLegend Biotech (NASDAQ:LEGN - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.34) by $0.19. Legend Biotech had a negative return on equity of 29.69% and a negative net margin of 66.92%.March 12, 2025 | marketbeat.comLegend Biotech reports Q4 adjusted EPS (15c), consensus (38c)March 11, 2025 | markets.businessinsider.comLegend Biotech reports Q4 earnings beat, revenue tops estimatesMarch 11, 2025 | in.investing.comLegend Biotech sees cash runway into 2Q26March 11, 2025 | markets.businessinsider.comCompared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key MetricsMarch 11, 2025 | msn.comLegend Biotech's Carvykti Is Taking Off, And It's Still Early (Rating Upgrade)March 11, 2025 | seekingalpha.comLegend Biotech Corporation (LEGN) Q4 2024 Earnings Call TranscriptMarch 11, 2025 | seekingalpha.comLegend Biotech Reports Fourth Quarter and Full Year 2024 Results and Recent HighlightsMarch 11, 2025 | globenewswire.comCandriam S.C.A. Purchases 27,465 Shares of Legend Biotech Co. (NASDAQ:LEGN)Candriam S.C.A. boosted its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 7.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 393,452 shares of the company's stock after acquiring an additioMarch 8, 2025 | marketbeat.comLegend Biotech (LEGN) Expected to Announce Earnings on TuesdayLegend Biotech (NASDAQ:LEGN) will be releasing earnings before the market opens on Tuesday, March 11, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=669771)March 4, 2025 | marketbeat.comNINE MASTS CAPITAL Ltd Has $1.25 Million Stock Position in Legend Biotech Co. (NASDAQ:LEGN)NINE MASTS CAPITAL Ltd cut its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 29.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 38,466 shares of the company's stock after selliMarch 3, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Bought by New York State Common Retirement FundNew York State Common Retirement Fund increased its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 196.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,276 shares of the company'sMarch 3, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Receives Average Rating of "Buy" from AnalystsLegend Biotech Co. (NASDAQ:LEGN - Get Free Report) has earned an average rating of "Buy" from the twelve ratings firms that are presently covering the company, Marketbeat Ratings reports. Twelve research analysts have rated the stock with a buy recommendation. The average 12-month price target amoFebruary 28, 2025 | marketbeat.comLos Angeles Capital Management LLC Buys Shares of 172,440 Legend Biotech Co. (NASDAQ:LEGN)Los Angeles Capital Management LLC purchased a new position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 172,440 shares of the company's stock, vFebruary 27, 2025 | marketbeat.comLegend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 ResultsFebruary 26, 2025 | markets.businessinsider.comWhy Legend Biotech Corporation (LEGN) is the Most Oversold Pharma Stock to Buy According to AnalystsFebruary 23, 2025 | msn.comMarket Concerns Put Pressure on Legend Biotech Corporation (LEGN) SharesFebruary 21, 2025 | msn.comLegend Biotech Corporation (LEGN): One of the Most Oversold Healthcare Stocks to Buy NowFebruary 20, 2025 | msn.comAlberta Investment Management Corp Has $4.40 Million Position in Legend Biotech Co. (NASDAQ:LEGN)Alberta Investment Management Corp boosted its holdings in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 143.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 135,259 shares of the companyFebruary 20, 2025 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Shares Sold by TimesSquare Capital Management LLCTimesSquare Capital Management LLC trimmed its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 99.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,912 shares of the company's stocFebruary 20, 2025 | marketbeat.comEmpire Life Investments Inc. Acquires 38,043 Shares of Legend Biotech Co. (NASDAQ:LEGN)Empire Life Investments Inc. lifted its holdings in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 38.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 136,731 shares of the company's stock after buying an additional 3February 16, 2025 | marketbeat.comIs Legend Biotech (LEGN) the Best Mid-Cap Growth Stock to Buy According to Analysts?February 14, 2025 | msn.com Remove Ads Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address LEGN Media Mentions By Week LEGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼0.620.68▲Average Medical News Sentiment LEGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼116▲LEGN Articles Average Week Remove Ads Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ONC News BNTX News TEVA News SMMT News ITCI News MRNA News GMAB News RDY News VTRS News ASND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LEGN Stock Free LEGN Stock Alerts